Treating children and adults who have latent tuberculosis infection (LTBI) with 4 months of rifampin (Rifadin, Sanofi-Aventis) had similar rates of safety and efficacy but a better adherence rate than ...

DENVER -- In patients with tuberculosis (TB), a novel fixed-dose combination of alpibectir-ethionamide had similar levels of bactericidal activity as isoniazid, with no serious adverse events and good ...

A study examining pharmacokinetic interactions between the first-line HIV drug dolutegravir and a once-weekly tuberculosis regimen was terminated early after NIH researchers found that the combined ...

Treatment of latent tuberculosis is set to transform after a pair of studies revealed that a shorter treatment was safer and more effective in children and adults compared to the current standard.

Study results help clarify how to safely prevent tuberculosis (TB) in women living with HIV who are pregnant or have recently given birth, are taking antiretroviral therapy, and live where TB is ...

Please provide your email address to receive an email when new articles are posted on . Drugs designed to treat heartburn may also help with tuberculosis by accelerating the treatment process, ...

Treatment of latent tuberculosis has never been a simple affair. Nine months of a drug known as isoniazid, taken daily, is the standard of care and can help clear the infection. But it also causes ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Laboratory tests of a new type of antibiotic suggest it might revolutionize the treatment of tuberculosis, a global killer disease that has become increasingly resistant to current drugs and which is ...

Montreal, Aug. 1, 2018 - Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a ...